Rivera Saldana Carlos D, Beletsky Leo, Borquez Annick, Kiene Susan M, Strathdee Steffanie A, Zúñiga María Luisa, Martin Natasha K, Cepeda Javier
Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
School of Public Health, San Diego State University, San Diego, CA, USA.
Addiction. 2021 Oct;116(10):2724-2733. doi: 10.1111/add.15445. Epub 2021 Mar 3.
Syringe-sharing among people who inject drugs, which can occur during incarceration and post-release, has been linked with increased risk of blood-borne infections. We aimed to investigate the cumulative effect of repeated incarceration and the post-release period on receptive syringe-sharing.
Ongoing community-based cohort, recruited through targeted sampling between 2011 and 2012 with 6-month follow-ups.
Tijuana, Mexico.
Sample of 185 participants (median age 35 years; 67% female) with no history of incarceration at study entry, followed to 2017.
Cumulative incarceration and post-release period were constructed from incarceration events reported in the past 6 months for each study visit. Receptive syringe-sharing in the past 6 months was assessed as a binary variable. We used logistic regression with generalized estimating equations to examine the association between cumulative incarceration events and the post-release period with receptive syringe-sharing over time. Missing data were handled through multiple imputation.
At baseline, 65% of participants engaged in receptive syringe-sharing in the prior 6 months. At follow-up, 150 (81%) participants experienced a total of 358 incarceration events [median = 2, interquartile range (IQR) = 1-3]. The risk of receptive syringe-sharing increased with the number of repeated incarcerations. Compared with never incarcerated, those with one incarceration had 1.28 [95% confidence interval (CI) = 0.97-1.68] higher adjusted odds of syringe-sharing; two to three incarcerations, 1.42 (95% CI = 1.02-1.99) and more than three incarcerations, 2.10 (95% CI = 1.15-3.85). Participants released within the past 6 months had 1.53 (95% CI = 1.14-2.05) higher odds of sharing syringes compared with those never incarcerated. This post-release risk continued up to 1.5 years post-incarceration (adjusted odds ratio = 1.41, 95% CI = 1.04-1.91), but then waned.
A longitudinal community cohort study among people who inject drugs suggested that the effects of incarceration on increased injecting risk, measured through syringe-sharing, are cumulative and persist during the post-release period.
注射毒品者之间共用注射器的行为,可能发生在监禁期间及出狱后,与血源性感染风险增加有关。我们旨在调查反复监禁及出狱后阶段对接受性共用注射器行为的累积影响。
基于社区的前瞻性队列研究,于2011年至2012年通过目标抽样招募,每6个月随访一次。
墨西哥蒂华纳。
185名参与者(年龄中位数35岁;67%为女性)样本,研究开始时无监禁史,随访至2017年。
根据每次研究访视时报告的过去6个月内的监禁事件构建累积监禁时间和出狱后阶段。将过去6个月内的接受性共用注射器行为评估为二元变量。我们使用广义估计方程的逻辑回归来检验累积监禁事件和出狱后阶段与接受性共用注射器行为随时间的关联。缺失数据通过多重填补法处理。
在基线时,65%的参与者在之前6个月内有接受性共用注射器行为。随访时,150名(81%)参与者共经历358次监禁事件[中位数 = 2,四分位间距(IQR)= 1 - 3]。接受性共用注射器的风险随着反复监禁次数的增加而增加。与从未被监禁者相比,有过一次监禁经历者共用注射器的调整后比值比高1.28[95%置信区间(CI)= 0.97 - 1.68];有过两至三次监禁经历者为1.42(95% CI = 1.02 - 1.99),有过三次以上监禁经历者为2.10(95% CI = 1.15 - 3.85)。在过去6个月内出狱的参与者与从未被监禁者相比,共用注射器的比值比高1.53(95% CI = 1.14 - 2.05)。这种出狱后的风险在监禁后长达一年半的时间内持续存在(调整后比值比 = 1.41,95% CI = 1.04 - 1.91),但随后逐渐减弱。
一项针对注射毒品者的纵向社区队列研究表明,通过共用注射器衡量,监禁对增加注射风险的影响是累积性的,且在出狱后阶段持续存在。